COST-EFFECTIVENESS OF A PHYSICAL ACTIVITY LOYALTY SCHEME FOR BEHAVIOUR CHANGE MAINTENANCE IN WORK SETTINGS- AN ECONOMIC EVALUATION ALONGSIDE A CLUSTER RANDOMISED CONTROLLED TRIAL
Author(s)
Xin Y1, Boyer N2, Hunter RF3, Gough A3, Murray J3, Tang J3, Brennan S3, Chrzanowski-Smith O3, Carlin A3, Patterson C3, Longo A3, Hutchinson G3, Prior L3, Tully MA3, French DP4, Adams J5, Kee F3, McIntosh E1
1University of Glasgow, Glasgow, UK, 2University of Chicago, Chicago, IL, USA, 3Queen’s University Belfast, Belfast, UK, 4University of Manchester, Manchester, UK, 5University of Cambridge, Cambridge, UK
OBJECTIVES: The Physical Activity Loyalty (PAL) scheme is a public health intervention aiming to increase physical activity in workplaces by providing financial incentives to employees. The objective of this study was to conduct an economic evaluation alongside a cluster randomised controlled trial comparing the PAL scheme and the control group, using both a cost-utility framework from the public sector perspective and a cost-benefit framework from the employer’s perspective. METHODS: RESULTS: The intervention was £25.85 (95%CI -29.89,81.60) more costly per participant but had no effect on QALYs (incremental QALY=-0.0000891,95%CI -0.008,0.008). The bootstrapped cost and QALY pairs spread over the four quadrants of the cost-effectiveness plane indicating large uncertainty. Nevertheless, the intervention appears likely to be cost-effective in the subgroup that had a high level of availability of physical activity opportunities with 76.8% bootstrapped iterations generating a cost-effective estimate under the £20,000/QALY threshold. Besides, the intervention group was estimated to reduce absenteeism by 2.59 hours (p=0.62) per month compared with the control group. At current intervention costs (=£55.68), the probability that the PAL scheme is cost saving for employers is 57%-64% for employees with low to high salary levels. CONCLUSIONS: There was large variability across participants in their resource use and especially utility values, leading to a great uncertainty in the cost-effectiveness estimate. A personalized HTA approach is warranted in future studies to provide recommendations with a greater certainty.
Conference/Value in Health Info
2018-09, ISPOR Asia Pacific 2018, Tokyo, Japan
Value in Health, Vol. 21, S2 (September 2018)
Code
PMU29
Topic
Economic Evaluation
Topic Subcategory
Cost-comparison, Effectiveness, Utility, Benefit Analysis
Disease
Multiple Diseases, Reproductive and Sexual Health